Country:China (Mainland)
Year Established: 2009Business type: Other
Integral:
1. Brief introduction of Mirodenafil
Mirodenafil (CAS NO. 862189-95-5) is a white crystalline powder. The Systematic (IUPAC) name of this chemical is 5-Ethyl-3,5-dihydro-2-[5-([4-(2-hydroxyethyl)-1-piperazinyl]sulfonyl)-2-propoxyphenyl]-7-propyl-4H-pyrrolo[3,2-d]pyrimidin-4-one. The formula of Mirodenafil is C26H37N5O5S. With the molecular weight 531.67, Mirodenafil is marketed under the trade name of Mvix tab which comes in different doses(50 mg,100 mg). In addition, Mirodenafil belongs to a class of drugs called PDE5 inhibitors.
2. Other properties of Mirodenafil
Mirodenafil structure:

(1)XLogP3-AA: 2.2; (2)H-Bond Donor: 2; (3)H-Bond Acceptor: 7; (4)Rotatable Bond Count: 11; (5)Tautomer Count: 3; (6)Exact Mass: 531.25154; (7)MonoIsotopic Mass: 531.25154; (8)Topological Polar Surface Area: 125; (9)Heavy Atom Count: 37; (10)Formal Charge: 0; (11)Complexity: 902; (12)Isotope Atom Count: 0; (13)Defined Atom Stereocenter Count: 0; (14)Undefined Atom Stereocenter Count: 0; (15)Defined Bond Stereocenter Count: 0; (16)Undefined Bond Stereocenter Count: 0; (17)Covalently-Bonded Unit Count: 1; (18)Feature 3D Acceptor Count: 5; (19)Feature 3D Donor Count: 3; (20)Feature 3D Cation Count: 2; (21)Feature 3D Hydrophobe Count: 2; (22)Feature 3D Ring Count: 4; (23)Effective Rotor Count: 12.2; (24)Conformer Sampling RMSD: 1.2.
Mirodenafil (CAS NO. 862189-95-5) can be also used in the nervous system. HANGZHOU HOLYPHARM BIOTECH CO.,LTD is one suppliers of Mirodenafil in China. 99% Mirodenafil in the aluminum bag can be provided to you. And this one ever exported to India, Vietnam, Latin America, Turkey, etc. Therefore, when you are seeking the cooperation of this chemical, you can find it in Holypharm.
What is Arixtra and arixtra 2.5 mg? Arixtra is a synthetic pentasaccharide anticoagulant. The HANGZHOU HOLYPHARM can provide arixtra 99% to you.
What is Fondaparinux sodium and its properties? Fondaparinux sodium is a white crystalline powder and similar to enoxaparin in reducing the risk of ischemic events at nine days.
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View